CTRI/2011/04/001686已完成3 期
Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures in a Double-blind, Randomised, Placebo-controlled, Parallel-group, Multicentre Trial
Bial Portela C SA0 个研究点目标入组 615 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 615
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Diagnosis of epilepsy for at least 12 months prior
- •to screening
- •2.At least 4 partial-onset seizures in the 4 weeks
- •prior to screening
- •3.Currently taking 1 or 2 AEDs
- •4.Aged 18+ years
排除标准
- •1Only simple partial seizures with no motor
- •symptomatology
- •2Primarily generalised seizures
- •3Known progressive neurological disorders
- •4Currently taking oxcarbazepine
研究者
相似试验
招募中
3 期
Efficacy and safety of Eslicarbazepine Acetate (BIA 2-093) as single therapy for patients with newly diagnosed partial-onset seizures - ESL extension studyG40.0G40.1G40.2EpilepsyRBR-93gkd4Instituto de Neurologia de Curitiba
进行中（未招募）
1 期
Eslicarbazepine Acetate (BIA 2-093) as Therapy for Refractory Partial Seizures in Childrechildren and adolescents with refractory partial epileptic seizuresMedDRA version: 14.0Level: PTClassification code 10015037Term: EpilepsySystem Organ Class: 10029205 - Nervous system disordersEUCTR2007-001887-55-ATBIAL - Portela & Ca, S.A.315
进行中（未招募）
1 期
Efficacy and safety of eslicarbazepine acetate (BIA 2-093) as monotherapy for patients with newly diagnosed partial-onset seizures - open label extension study with eslicarbazepine acetateAdult patients with recently diagnosed partial-onset seizuresMedDRA version: 21.1Level: LLTClassification code 10065336Term: Partial epilepsySystem Organ Class: 100000004852EUCTR2015-001243-36-ITBIAL-PORTELA & Cª, S.A.207
进行中（未招募）
1 期
Efficacy and safety of eslicarbazepine acetate (BIA 2-093) as adjunctive therapy for refractory partial seizures in children: a double-blind, randomised, placebo-controlled, parallel-group, multicentre clinical trialEUCTR2007-001887-55-GBBIAL - Portela & Ca, S.A.304
进行中（未招募）
1 期
Eslicarbazepine Acetate (BIA 2-093) as Therapy for Refractory Partial Seizures in Childrechildren and adolescents with refractory partial epileptic seizuresMedDRA version: 16.0Level: PTClassification code 10015037Term: EpilepsySystem Organ Class: 10029205 - Nervous system disordersEUCTR2007-001887-55-CZBIAL - Portela & Ca, S.A.315